TEM

Tempus AI, Inc.

Healthcare · $14.5B market cap

Verdict

We can't put a fair value on TEM right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth—?
Sales growth43.6% a year✓
Free cash flow growth—?
Return on invested capital-42.1%✗

Follow TEM

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

2 of the investors we track hold TEM. In Q1 2026, 1 added, 1 trimmed and 1 sold out. Who we track

Moves in Q1 2026

Added: Samantha McLemore

Trimmed: Duan Yongping

Sold out: Polen Capital Management

Insider activity

Since Sep 1, 2026: no open-market purchases and 6 sales worth $2.0M. Why purchases matter

Sales

About Tempus AI, Inc.

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as…

Medical - Healthcare Information Services

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works